• About us
  • Investment profile
  • Investment partners
  • Investment approach
  • Portfolio
  • News and views
  • Contacts
Mackintosh Capital invests in and supports small and medium enterprises (SMEs) as a catalyst for realising their potential
← Oncimmune’s EarlyCDT-Lung Blood Test detects 8 out of 10 with lung cancer
Oncimmune announces intention to float →

Oncimmune acquires dedicated commercial testing facility for EarlyCDT-Lung from Health Diagnostic Laboratory, Inc

Posted on September 24, 2015 by admin

For full press release from the company, please click here:

http://cdn2.hubspot.net/hubfs/188206/docs/Oncimmune_HDL_release_24_9_15_FINAL.pdf?t=1445612617494

Mackintosh Capital LLP, Mackintosh House, 136 Newport Road, Cardiff, CF24 1DJ | Tel: +44 (0)2921 25 1455
Copyright 2010 Mackintosh Capital LLP
All rights reserved

Terms of Use and Privacy Policy